世界の再生医療市場：製品・治療法・用途・地域別 - 成長、動向、予測

世界の再生医療市場は、2018年から2023年にかけて14%のCAGRで推移し、2023年までに42億3,000万米ドルに達することが予測されています。地域別では、多くの先進技術を有する北米が最大市場となっています。

当レポートでは、世界の再生医療市場を調査し、市場の概要、技術タイプ・応用領域・地域別の市場動向、市場規模の推移と予測、市場シェア、市場促進・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な推論

第5章 市場概要

• 現在の市場シナリオ
• ファイブフォース分析
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係

第6章 市場力学

• 市場促進要因
  • 幹細胞技術の導入増加
  • 再生医療の技術的利点
• 市場阻害要因
  • 倫理的および規制上の問題
  • 治療費の高さと認識の低さ
• 市場機会
• 主な課題

第7章 世界の再生医療市場：市場区分

• 技術タイプ別
  • 幹細胞治療
  • 生体材料
  • 組織工学
• 応用領域別
  • 代替骨
  • 骨関節疾患
  • 皮膚
  • 心臓血管系
  • 中枢神経系
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 南米

第8章 競合情勢

• M&A
• 協定、協力、提携
• 新製品の上市

第9章 主要企業

• ACELITY
• OSIRIS THERAPEUTICS
• INTEGRA LIFESCIENCES CORPORATION
• COOK BIOTECH INCORPORATED
• ORGANOGENESIS INC
• MERCK & CO
• その他の主要企業

第10章 市場の将来展望

The key factors propelling the growth of the global regenerative medicine market are the increasing adoption of stem cell technologies, gene therapies, and tissue engineering, and the technological advancements in regenerative medicine.

Stem cell technology is a rapidly developing technology that plays a major role in regenerative medicine, as it also serves the disciplines of tissue engineering, developmental cell biology, cellular therapeutics, gene therapy, chemical biology, and nanotechnology. Stem cells offer the possibility of replacing the cells and tissues to treat various conditions including spinal cord injury, arthritis, and Parkinson's disease, among others. The applications of stem cell technologies in the treatment of diseases have ultimately increased the overall adoption rate of these technologies across the world.

The market is found experiencing the major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. There are also various recent advancements in regenerative medicine, including the regenerated tracheas for transplant, 3D bioprinting, stem cell treatments for vision loss, and stem cell treatments for heart repair.

The current market is also witnessing extensive R&D activities. Apart from the R&D activities being conducted by private players, there is significant involvement of academic institutions for conducting various research. Therefore, in the future, several new biotech and medtech companies are expected to come up, as the result of the current R&D endeavors across the world.

Key Market Trends

Dermatology is the Segment by Application that is Expected to be the Largest During the Forecast Period

Dermatology is estimated to have the largest share in revenue generation, and this high contribution is attributive to the presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Therefore, there is a broad range of products present, from patches to cure small injuries to matrix and grafts for chronic wounds and burns. Thus, the segment is expected to continue to dominate the market through the forecast period.

The increasing number of accidents and bone defects is also expected to drive the regenerative medicine market. There are also several research studies that are being conducted on tissue engineering for the development of bone graft substitutes, with the help of regenerative medicine. So, with the new advances in bone graft, the market is expected to grow over the forecast period.

North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period

North America is estimated to have the largest share, in terms of revenue, owing to the presence of major players and rapid advances in technology, along with high investments in stem cell and oncology research. There is also an increasing prevalence of diseases, such as cancer and diabetes, which can now be cured by various stem cell therapies. Additionally, the awareness regarding the available stem cell procedures and therapies among people is rising, which in turn, is increasing the demand for the overall market.

Competitive Landscape

The global regenerative medicine market is highly competitive. The small-scale companies are also merging with large companies to develop tissue models for research and therapeutic purposes. Thus, companies are making considerable investments in novel technologies, thus driving the market. Moreover In the coming years few other players are expected to enter into the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Adoption of Stem Cell Technology
  • 4.2.2 Technological Advancements in Regenerative Medicine
• 4.3 Market Restraints
  • 4.3.1 Regulatory and Ethical Issues
  • 4.3.2 High Cost of Treatments
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Type of Technology
  • 5.1.1 Stem Cell Therapy
  • 5.1.2 Biomaterial
  • 5.1.3 Tissue Engineering
  • 5.1.4 Other Types of Technologies
• 5.2 By Application
  • 5.2.1 Bone Graft Substitutes
  • 5.2.2 Osteoarticular Diseases
  • 5.2.3 Dermatology
  • 5.2.4 Cardiovascular
  • 5.2.5 Central Nervous System
  • 5.2.6 Other Applications
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East & Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East & Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Allergan Plc
  • 6.1.2 Osiris Therapeutics (Smith & Nephew)
  • 6.1.3 Integra Lifesciences
  • 6.1.4 Cook Biotech Incorporated
  • 6.1.5 Organogenesis Inc.
  • 6.1.6 Baxter
  • 6.1.7 Medtronic Plc
  • 6.1.8 Thermo Fisher Scientific
  • 6.1.9 Sigma-Aldrich Co.
  • 6.1.10 Becton Dickinson and Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS